bioRxivPathology
Deep learning from multiple experts improves identification of amyloid neuropathologies
D. R. Wong, Z. Tang, N. C. Mew, S. Das, J. Athey, K. E. McAleese, J. K. Kofler, M. E. Flanagan, E. Borys, C. L. White, A. J. Butte, B. N. Dugger, M. J. Keiser
Abstract
Pathologists can label pathologies differently, making it challenging to yield consistent assessments in the absence of one ground truth. To address this problem, we present a DL approach that draws on a cohort of experts, weighs each contribution, and is robust to noisy labels. We collected 100,495 annotations on 20,099 candidate amyloid beta neuropathologies (cerebral amyloid angiopathy (CAA), and cored and diffuse plaques) from three institutions, independently annotated by five experts. DL methods trained on a consensus-of-two strategy yielded 12.6-26% improvements by area under the precision recall curve (AUPRC) when compared to those that learned individualized annotations. This strategy surpassed individual-expert models, even when unfairly assessed on benchmarks favoring them. Moreover, ensembling over individual models was robust to hidden random annotators. In blind prospective tests of 52,555 subsequent expert-annotated images, the models labeled pathologies like their human counterparts (consensus model AUPRC=0.74 cored; 0.69 CAA). This study demonstrates a means to combine multiple ground truths into a common-ground DL model that yields consistent diagnoses informed by multiple and potentially variable expert opinion.
- assay: imaging
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- research focus: cell-cell communication
- approach: deep learning
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Evaluation of Deep Learning Algorithms to Predict Multiple Dementia-Related Neuropathologies from Brain MRI, Clinical and Genetic Data
Tamoghna Chattopadhyay, R Varshney Kush, … Paul M. Thompson·International Symposium on Medical Information Processing and Analysis (SIPAIM)Peer-reviewed·Nov 18, 2025
- Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline
Z. Tang, K. V. Chuang, … B. N. Dugger·bioRxiv·Mar 11, 2019
- Learning fast and fine-grained detection of amyloid neuropathologies from coarse-grained expert labels
D. R. Wong, S. D. Magaki, … M. J. Keiser·bioRxiv·Jan 13, 2023
- A Scalable High Throughput Fully Automated Pipeline for the Quantification of Amyloid Pathology in Alzheimer's Disease Using Deep Learning Algorithms
Vivek Gopal Ramaswamy, Monika Ahirwar, … Steven M. Finkbeiner·bioRxiv·May 19, 2023
- Development and validation of a deep learning framework for Alzheimers disease classification
Shangran Qiu, Prajakta S. Joshi, … Vijaya B. Kolachalama·BrainPeer-reviewed·Apr 8, 2020
- Automated segmentation by deep learning of neuritic plaques and neurofibrillary tangles in brain sections of Alzheimer's Disease Patients
Léa Ingrassia, Susana Boluda, … Lev Stimmer·bioRxiv·Oct 31, 2023